Robert Otte, MD
Allergy & Immunology · Pittsburgh, PANPI 1386689305
Payments from drug & device makers
Across 20 payments — averaging $58.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$327
- Genentech USA, Inc.$131
- AbbVie$129
- Grifols USA, LLC$125
- Blueprint Medicines Corporation$124
- Pharming Healthcare, Inc.$103
- plus $228 from 5 others
What the payments were for
- Food & beverage$1,11696%
- Education$514%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 5 | $327 |
| Genentech USA, Inc. | 1 | $131 |
| AbbVie | 2 | $129 |
| Grifols USA, LLC | 1 | $125 |
| Blueprint Medicines Corporation | 1 | $124 |
| Pharming Healthcare, Inc. | 1 | $103 |
| Sanofi | 1 | $100 |
| Novo Nordisk | 4 | $58 |
| CSL Behring | 2 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,168 in reported general payments places this provider in the 35th percentile of 175 allergy & immunology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 16 | $107,173 |
| GammaplexImmun Glob G/Sorb/Gly/Iga 0-50 | 17 | $70,974 |
| Dupixent SyringeDupilumab | 16 | $61,923 |
| NucalaMepolizumab | 16 | $58,608 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 64 | $47,997 |
| Advair HfaFluticasone Propion/Salmeterol | 51 | $20,945 |
| Breo ElliptaFluticasone/Vilanterol | 28 | $15,802 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 80 | $15,154 |
| Fluticasone Propionate HfaFluticasone Propionate | 24 | $5,802 |
| Arnuity ElliptaFluticasone Furoate | 18 | $5,288 |
| Azelastine Hcl | 171 | $4,245 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 24 | $4,183 |
| Wixela InhubFluticasone Propion/Salmeterol | 22 | $3,430 |
| Montelukast Sodium | 315 | $3,316 |
| Asmanex HfaMometasone Furoate | 17 | $2,564 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Pittsburgh
- Sergei BelenkyPittsburgh$775K
- Hey ChongPittsburgh$74K
- Christine RauscherPittsburgh$52K
- Merritt FajtPittsburgh$10K
- Drew WeissmanPhiladelphia$15.3M
- Timothy CraigHershey$2M
- Eric SchenkelBethlehem$845K
- Sandra GawchikUpland$390K
- Anthony RooklinGlen Mills$319K
- Corinna BowserNarberth$229K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.